Wealthspire Advisors (New York)’s RenovoRx RNXT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Hold
252,525
﹤0.01% 1075
2026
Q1
$255K Hold
252,525
﹤0.01% 777
2025
Q4
$212K Buy
+252,525
New +$253K ﹤0.01% 950

Other funds holding RNXT

Wealthspire Advisors (New York)'s RNXT Position: Q2 2026 in Review

Wealthspire Advisors (New York) held its RenovoRx (RNXT) position steady in Q2 2026 at 252,525 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #1075.

Wealthspire Advisors (New York) first reported a position in RNXT in Q4 2025 and has held it in 3 quarters since. The position peaked at $255K in Q1 2026. 28 funds tracked by Wall St. Rank hold RNXT as of Q2 2026.

  • Wealthspire Advisors (New York) held 252,525 shares of RenovoRx worth $247K as of Q2 2026.
  • Wealthspire Advisors (New York) left its RenovoRx share count unchanged in Q2 2026.
  • RenovoRx made up ﹤0.01% of Wealthspire Advisors (New York)'s portfolio in Q2 2026, its #1075 holding.
  • Wealthspire Advisors (New York) first reported a position in RenovoRx in Q4 2025 and has held it in 3 quarters since.
  • Wealthspire Advisors (New York)'s RenovoRx position peaked at $255K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held RenovoRx as of Q2 2026.

Based on Wealthspire Advisors (New York)'s 13F filing for Q2 2026, filed 11 Aug 2026.